The government is to continue a program worth $150 million a year that funds clinical trials on diabetes for a further two years, following the approval of president Barack Obama.
Established in 1997, the Special Diabetes Program funds research on Type 1 and Type 2 diabetes in Native American populations, through the National Institutes of Health and the Centers for Disease Control and Prevention.
The diabetes research advocacy group JDRF said the initiative supports one-third of all federally-funded Type 1 clinical trials in the US. Reauthorization to continue the program came as part of a larger, $200-billion bill that addressed Medicare payments and other healthcare issues.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.